Back to search

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

Data up to Jan 2025

Published2012
Citations1,274
References42

Total Citations Per Year

Abstract

References (42)

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

2000 • 4,853 citations

PD-1 and Its Ligands in Tolerance and Immunity

2008 • 4,838 citations

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2002 • 4,625 citations

Restoring function in exhausted CD8 T cells during chronic viral infection

2005 • 3,743 citations

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

1992 • 2,906 citations

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

2002 • 2,879 citations

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

2001 • 2,746 citations

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

2010 • 2,721 citations

CTLA-4 Control over Foxp3 + Regulatory T Cell Function

2008 • 2,656 citations

Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor

1999 • 2,574 citations

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1999 • 2,380 citations

THE B7 FAMILY REVISITED

2005 • 2,239 citations

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

2009 • 1,887 citations

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

2008 • 1,887 citations

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

2009 • 1,604 citations

Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses

2007 • 1,603 citations

Inhibitory B7-family molecules in the tumour microenvironment

2008 • 1,511 citations

PD-1 and PD-1 ligands: from discovery to clinical application

2007 • 1,199 citations

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

2003 • 1,080 citations

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

2009 • 882 citations

B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

2001 • 850 citations

Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 • 792 citations

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

2010 • 767 citations

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

2004 • 748 citations

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

1990 • 745 citations

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

2008 • 653 citations

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

2003 • 644 citations

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

2011 • 598 citations

Cancer Immunotherapy Comes of Age

2011 • 560 citations

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

2008 • 480 citations

Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes

2005 • 409 citations

The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells

2011 • 406 citations

B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance

2010 • 311 citations

PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

2011 • 290 citations

Human prostate‐infiltrating CD8+ T lymphocytes are oligoclonal and PD‐1+

2009 • 227 citations

The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo

2011 • 179 citations

PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients

2009 • 157 citations

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

2005 • 152 citations

Constitutive and Inducible Expression of B7 Family of Ligands by Human Airway Epithelial Cells

2005 • 138 citations

Dual biological effects of the cytokines interleukin-10 and interferon-γ

2011 • 126 citations

Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques

2010 • 123 citations

IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells

2005 • 111 citations

Cited By (0)

No citing papers found in database

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity (2012) – Current Opinion in Immunology | Metascience Observatory Explorer